2022.08.16
JunHe was the exclusive legal advisor to Shiseido (China) Investment Company Limited ("Shiseido China") and assisted the company in establishing the "Ziyue Fund" in partnership with Boyu Capital. Ziyue Fund is the first dedicated investment fund in mainland China led by an international beauty group and focuses on investment opportunities in emerging brands and related upstream and downstream technology companies in frontier markets such as beauty and health. Along with the initial closing of the fund, we assisted Ziyue Fund as the lead investor to invest in Jiangsu Chuangjian Medical Technology Company Limited ("Chuangjian Medical"), which specializes in recombinant collagen biomaterials. With this investment, Shiseido China lead the way in entering the capital market in the new beauty biomaterial sector. It plans to combine the strengths of both companies in the areas of product development and raw material supply and will channel resources to further promote the development of the beauty industry in China.
Shiseido was founded in 1872 and now operates in more than 120 countries and regions worldwide. Shiseido entered the Chinese market in 1981, as the first international cosmetics group. With over 40 years in the country, Shiseido China now integrates research and development, production, sales and service, and operates over twenty well-known brands in China. In 2017, China became the largest overseas market for Shiseido Group. 2022 sees the 150th anniversary of Shiseido Group, and the successful establishment of Ziyue Fund marks a new chapter in its commitment to the Chinese market.
As the exclusive legal advisor to Shiseido China, we were deeply involved in the design of the fund structure and the management arrangements throughout the fund establishment process. JunHe’s team provided Shiseido China with legal assessments and advice, assisted in reviewing, negotiating and revising a full set of legal documents for the fund establishment, completed the anti-trust filing for the fund establishment, reviewed and revised the agreements related to the opening of various accounts for the fund, and assisted the fund in completing the product filing with the fund association. With respect to the fund's investment in Chuangjian Medical, JunHe assisted Shiseido China in completing the legal risk assessment of the target company and led the drafting, negotiation and signing of the transaction documents at various stages, and assisted the fund in successfully completing the closing of the investment.
We leveraged our rich experience in fund establishment and investment, excellent multi-cultural understanding and communication skills, executive level coordination skills, to assist Shiseido China in establishing the first dedicated investment fund of an international beauty group in mainland China and complete the first investment project of such fund. Our service has been highly recognized and praised by Shiseido China.
The lead lawyers for this project were SHANG, Shiming (George), CHEN, Yan and Chen, Yijia, and the lead lawyer for the antitrust legal services was GONG, Mingfang.
